Top 10 Performing Stocks For 2018

November 29, 2016: Markets opened higher Tuesday following the Commerce Department’s second estimate of third quarter GDP growth of 3.2%. The Conference Board’s consumer confidence index has returned to pre-recession levels. Tuesday’s best performing sectors have been healthcare and real estate. The energy sector was down about 1%. WTI crude oil for January delivery settled at $45.23 a barrel, down 3.9% on the day. February gold lost 0.3% on the day to settle at $1,190.80. Equities were headed for a higher close before the bell as the DJIA traded up 0.6% for the day, the S&P 500 traded up 0.6%, and the Nasdaq Composite traded up 0.14%.

The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was UnitedHealth Group Inc. (NYSE: UNH) which traded up 3.44% at $157.35. The stock’s 52-week range is $107.51 to $158.12, and the high was posted this morning. Trading volume was about 15% above the daily average of around 3.7 million. The healthcare giant’s 2017 forecast was better than expected today.

Top 10 Performing Stocks For 2018: Northwest Natural Gas Company(NWN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NW Natural (NYSE:NWN) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.

Top 10 Performing Stocks For 2018: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)– which is an exchange-traded fund that holds nearly 200 biotech stocks — has drastically underperformed the S&P 500 over the last three years. That fact suggests that there are bargains to be found in the biotech space.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) a good measure of small-cap biotech stocks gained almost 6% yesterday. Meanwhile, the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) jumped almost 4%. The biotech buying frenzy helped lift the Nasdaq Composite to a gain of almost 1% in Mondays session.

  • [By ]

    October was not kind to the biggest names in biotech. While smaller, more speculative biotech names consolidated, the big kids fell off a cliff. The biotech slide accelerated midway through the month, with both the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the smaller SPDR S&P Biotech ETF slipping more than 5%.

  • [By Jim Crumly]

    Biotech stocks had a big day, with theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) jumping 2.8%. The broad technology sector slipped, and theTechnology Select Sector SPDR ETF (NYSEMKT:XLK)lost 0.1%.

  • [By Benzinga News Desk]

    After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions: Link

Top 10 Performing Stocks For 2018: C.H. Robinson Worldwide, Inc.(CHRW)

Advisors’ Opinion:

  • [By Joseph Griffin]

    C. H. Robinson (NASDAQ:CHRW) declared a quarterly dividend on Thursday, May 10th, RTT News reports. Stockholders of record on Friday, June 1st will be paid a dividend of 0.46 per share by the transportation company on Friday, June 29th. This represents a $1.84 annualized dividend and a dividend yield of 2.18%.

Top 10 Performing Stocks For 2018: Cinemark Holdings Inc(CNK)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of institutional investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. increased its position in Cinemark by 73.2% during the fourth quarter. Victory Capital Management Inc. now owns 6,081,823 shares of the company’s stock worth $211,768,000 after buying an additional 2,570,923 shares in the last quarter. Rivulet Capital LLC increased its position in Cinemark by 88.0% during the fourth quarter. Rivulet Capital LLC now owns 2,859,216 shares of the company’s stock worth $99,558,000 after buying an additional 1,338,000 shares in the last quarter. River Road Asset Management LLC increased its position in Cinemark by 1.9% during the fourth quarter. River Road Asset Management LLC now owns 2,312,832 shares of the company’s stock worth $80,533,000 after buying an additional 42,982 shares in the last quarter. Bank of New York Mellon Corp increased its position in Cinemark by 4.0% during the fourth quarter. Bank of New York Mellon Corp now owns 1,728,543 shares of the company’s stock worth $60,187,000 after buying an additional 66,700 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Cinemark by 3.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,334,140 shares of the company’s stock worth $48,310,000 after buying an additional 43,606 shares in the last quarter. 94.03% of the stock is owned by institutional investors.

    ILLEGAL ACTIVITY WARNING: “$0.61 EPS Expected for Cinemark Holdings, Inc. (CNK) This Quarter” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/3362835/0-61-eps-expected-for-cinemark-holdings

  • [By Lisa Levin] Companies Reporting Before The Bell
    Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion.
    SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million.
    Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million.
    Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion.
    Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion.
    Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion.
    ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion.
    Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion.
    Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million.
    Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion.
    Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion.
    Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion.
    Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion.
    Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million.
    Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion.
    Groupon, Inc. (NASDAQ: GRPN) is projected to report
  • [By Shane Hupp]

    Hodges Capital Management Inc. raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 2.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,681 shares of the company’s stock after acquiring an additional 6,234 shares during the quarter. Hodges Capital Management Inc. owned approximately 0.27% of Cinemark worth $11,741,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 Performing Stocks For 2018: Coeur d’Alene Mines Corporation(CDE)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    There’s no way to sugarcoat it:2017 was not a particularly good year for shareholders of silver and gold miner Coeur Mining, Inc. (NYSE:CDE). When it comes to investing, though, you need to balance the past with the future, and this miner’s efforts in 2017 look like they will set up a much better long-term future. Here’s why precious metals investors should be taking a closer look at Coeur Mining, but probably shouldn’t rush to pull the trigger.

Top 10 Performing Stocks For 2018: Mercantile Bank Corporation(MBWM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Mercantile Bank Co. (NASDAQ:MBWM) have been given a consensus recommendation of “Hold” by the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $36.33.

Top 10 Performing Stocks For 2018: Amarin Corporation PLC(AMRN)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub upgraded shares of Amarin (NASDAQ:AMRN) from a strong sell rating to a sell rating in a report released on Friday morning.

    A number of other equities research analysts have also weighed in on AMRN. ValuEngine upgraded shares of Amarin from a sell rating to a hold rating in a report on Wednesday. Cantor Fitzgerald set a $10.00 price objective on shares of Amarin and gave the stock a buy rating in a report on Wednesday. HC Wainwright reiterated a buy rating on shares of Amarin in a report on Thursday, March 1st. Finally, Zacks Investment Research lowered shares of Amarin from a hold rating to a sell rating in a report on Friday, March 2nd. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Amarin currently has a consensus rating of Hold and a consensus target price of $7.75.

Top 10 Performing Stocks For 2018: LookSmart Ltd.(LOOK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Peel Hunt reissued their buy rating on shares of Lookers (LON:LOOK) in a research note issued to investors on Wednesday morning.

    A number of other equities analysts also recently weighed in on the stock. Numis Securities reaffirmed a buy rating and issued a GBX 130 ($1.76) price target on shares of Lookers in a research note on Wednesday, March 7th. JPMorgan Chase upped their price target on shares of Lookers from GBX 109 ($1.48) to GBX 130 ($1.76) and gave the stock an overweight rating in a research note on Thursday, March 8th. Liberum Capital reaffirmed a buy rating and issued a GBX 145 ($1.97) price target on shares of Lookers in a research note on Wednesday, March 7th. Finally, Canaccord Genuity reaffirmed a buy rating and issued a GBX 146 ($1.98) price target on shares of Lookers in a research note on Monday, March 5th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Lookers has an average rating of Buy and an average price target of GBX 137.71 ($1.87).

Top 10 Performing Stocks For 2018: Physicians Realty Trust(DOC)

Advisors’ Opinion:

  • [By Max Byerly]

    Physicians Realty Trust (NYSE:DOC) had its price target decreased by KeyCorp from $20.00 to $17.00 in a report issued on Tuesday, MarketBeat reports. KeyCorp currently has a buy rating on the real estate investment trust’s stock. KeyCorp also issued estimates for Physicians Realty Trust’s FY2018 earnings at $1.10 EPS and FY2019 earnings at $1.12 EPS.

  • [By Lee Jackson]

    Physicians Realty Trust (NYSE: DOC) investors receive a 6.05% yield. Shares traded at $15.15 early Thursday. The 52-week range is $14.31 to $21.85, and the posted consensus price objective is $17.59.

  • [By Logan Wallace]

    HL Financial Services LLC acquired a new position in Physicians Realty Trust (NYSE:DOC) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 55,982 shares of the real estate investment trust’s stock, valued at approximately $872,000.

Top 10 Performing Stocks For 2018: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By ]

    Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.

Leave a Reply

Your email address will not be published. Required fields are marked *